Active Pharma Inc.
Active Pharma Inc., headquartered in California, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in [year], the company has established a strong presence across major operational regions, focusing on both prescription and over-the-counter products. With a commitment to quality and efficacy, Active Pharma Inc. offers a diverse range of core products, including advanced formulations and generics that cater to various therapeutic areas. Their unique approach to research and development has positioned them as a trusted name in the market, achieving notable milestones in product launches and regulatory approvals. Recognised for their dedication to improving patient outcomes, Active Pharma Inc. continues to enhance its market position through strategic partnerships and a robust pipeline of future innovations.
DitchCarbon Score
How does Active Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Active Pharma Inc.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Active Pharma Inc.'s reported carbon emissions
In 2024, Active Pharma Inc. reported total carbon emissions of approximately 33,489,000 kg CO2e for Scope 1 and about 43,622,000 kg CO2e for Scope 2. This represents a significant increase in emissions compared to 2023, where Scope 1 emissions were around 11,168,000 kg CO2e and Scope 2 emissions were approximately 43,425,000 kg CO2e. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. Notably, the total Scope 1 and Scope 2 emission intensity in 2024 was reported at 10,890 kg CO2e per tonne, while in 2023, it was 8,890 kg CO2e per tonne. Currently, Active Pharma Inc. has not set specific reduction targets or climate pledges, indicating a potential area for future commitment in line with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 11,168,000 | 00,000,000 |
| Scope 2 | 43,425,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Active Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
